BIOMAT Database Logo BIOMAT Database Logo

[Nonspecific blood inhibitors of streptolysin O. I. Evaulation of its incidence]. 1968

L V Décourt, and M E Camargo, and S Kopersztych

UI MeSH Term Description Entries
D007565 Jaundice A clinical manifestation of HYPERBILIRUBINEMIA, characterized by the yellowish staining of the SKIN; MUCOUS MEMBRANE; and SCLERA. Clinical jaundice usually is a sign of LIVER dysfunction. Icterus,Jaundice, Hemolytic,Hemolytic Jaundice,Hemolytic Jaundices,Jaundices, Hemolytic
D008052 Lipid Metabolism, Inborn Errors Errors in the metabolism of LIPIDS resulting from inborn genetic MUTATIONS that are heritable. Lipid Metabolism, Inborn Error
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D005921 Glomerulonephritis Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY. Bright Disease,Kidney Scarring,Glomerulonephritides,Scarring, Kidney
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

L V Décourt, and M E Camargo, and S Kopersztych
[The nonspecific inhibition of streptolysin O and its detection].
December 1959, Revue francaise d'etudes cliniques et biologiques,
L V Décourt, and M E Camargo, and S Kopersztych
[Clinical importance of the presence of nonspecific inhibitors of streptolysin O].
November 1971, Pediatria polska,
L V Décourt, and M E Camargo, and S Kopersztych
[SERUM INHIBITORS OF STREPTOLYSIN O IN ANIMALS. I. INHIBITORS IN NORMAL AND ANIMALS IMMUNIZED AGAINST STREPTOLYSIN O].
March 1964, Annales de l'Institut Pasteur,
L V Décourt, and M E Camargo, and S Kopersztych
[Serum inhibitors of streptolysin "O". I. Experimental findings].
September 1968, Archives roumaines de pathologie experimentales et de microbiologie,
L V Décourt, and M E Camargo, and S Kopersztych
[The nonspecific inhibition of streptolysin O in liver diseases. Its significance and clinical value].
January 1962, Annales de biologie clinique,
L V Décourt, and M E Camargo, and S Kopersztych
[Study of serum inhibitors of streptolysin "O"].
September 1966, Archives roumaines de pathologie experimentales et de microbiologie,
L V Décourt, and M E Camargo, and S Kopersztych
[Considerations on non-specific inhibitors of streptolysin "O"].
June 1969, Medicina interna,
L V Décourt, and M E Camargo, and S Kopersztych
[STUDY OF NONSPECIFIC INHIBITION OF STREPTOLYSIN O. IV. AN IMPROVEMENT OF THE ALBUMIN TEST PERMITTING THE SPECIFIC DETERMINATION OF ANTISTREPTOLYSIN O IN THE PRESENCE OF NONSPECIFIC INHIBITORS].
October 1963, Comptes rendus des seances de la Societe de biologie et de ses filiales,
L V Décourt, and M E Camargo, and S Kopersztych
[Serum inhibitors of streptolysin "O" in acute epidemic hepatitis].
June 1970, Archiv fur Hygiene und Bakteriologie,
L V Décourt, and M E Camargo, and S Kopersztych
[Serum inhibitors of streptolysin O in primary liver cancer].
January 1968, Bulletin de la Societe medicale d'Afrique noire de langue francaise,
Copied contents to your clipboard!